Molecular Staging of Cancer /
An explosion of information has occurred since scientists began to define the molecular events that describe the malignant transformation and progression of cells and their development towards a life-threatening metastatic disease. The First International Congress on Molecular Staging of Cancer, hel...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2003.
|
| Series: | Recent results in cancer research ;
162. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- From the contents: The urokinase receptor (uPAR, CD87) as a target for tumor therapy
- Molecular regulation of urokinase receptor (u-PAR) gene expression as one potential concept for molecular staging and therapy
- Stromal cell involvement in cancer
- Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo
- Molecular mechanisms of carcinogenesis in gastric cancer
- Clinical implications of molecular diagnosis in HNPCC
- Minimal residual disease in gastric cancer
- Minimal residual disease in breast cancer and gynecological malignancies
- Clinical implications of the EGF-receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options
- Minimal residual disease in the bone marrow and peripheral blood of patients with metastatic breast cancer
- Estrogen receptor (ER) expression profile of disseminated epithelial tumor cells in the bone marrow of breast cancer patients
- Detection of circulating tumor cells in blood using an optimized density gradient centrifugation
- Antitumoral and antimetastatic effects of continuous particle mediated cytokine gene therapy
- Genetic subtyping of renal cell carcinoma by comparative genomic hybridization
- Telomere length and hTERT expression in patients with colorectal carcinoma
- Evaluation of the level of bFGF, VEGF, sICAM-1, sVCAM-1 in the serum of patients with thyroid cancer.